Through Drug Enforcement Administration (DEA) administrative procedures and Department of Justice (DOJ) civil and criminal actions, federal enforcement officials continue to closely scrutinize pharmacies and pharmacists in the United States for alleged violations of Controlled Substances Act (CSA) requirements.

As always, it is important for pharmacy professionals to be aware of the alleged violations being investigated by DEA and DOJ officials — including alleged failures to resolve red flags of abuse and diversion when filling prescriptions for controlled substances, alleged violations of CSA recordkeeping mandates, and other alleged wrongdoing — that have resulted in the revocation of DEA registrations and the imposition of civil and criminal penalties.

This white paper, brought to you by the experts at Thompson Controlled Substances, tracks and analyzes recent DEA and DOJ enforcement actions involving the dispensing and storage of controlled
substances and other important recent cases and settlements — all cautionary tales that should encourage pharmacies and pharmacists to scrutinize their operations to ensure compliance with complex and exacting federal requirements.